BIRC3 and glioblastoma: Given our previous findings with BIRC3 in GBM31, we hypothesized that BIRC3 might be a putative mediator and biomarker of hypoxia-driven survival adaptation in mesenchymal GBM, whereby hypoxia was a potential driver of BIRC3 expression.